Gülay Hergenç
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Neuroscience of respiration and sleep
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 45
- Epidemiology 35
- Adipokines, Inflammation, and Metabolic Diseases 24
- Liver Disease Diagnosis and Treatment 14
- Co-authors
- Altan Onat (73 shared papers)Günay Can (55 shared papers)Ahmet Karabulut (15 shared papers)Hüseyin Uyarel (17 shared papers)Hasan Kaya (2 shared papers)İbrahim Sarı (12 shared papers)Zekeriya Kaya (7 shared papers)Erkan Ayhan (8 shared papers)
- Journals
- Metabolism (10 papers)Atherosclerosis (5 papers)International Journal of Cardiology (4 papers)American Journal of Hypertension (4 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)
- Partner nations
- TürkiyeUnited KingdomGermany
In The Last Decade
Gülay Hergenç
77 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 115
- Endocrinology, Diabetes and Metabolism 1.3k
- Endocrine and Autonomic Systems 303
- Nephrology 230
- Cardiology and Cardiovascular Medicine 647
- Physiology 659
Countries citing papers authored by Gülay Hergenç
This map shows the geographic impact of Gülay Hergenç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülay Hergenç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülay Hergenç more than expected).
Fields of papers citing papers by Gülay Hergenç
This network shows the impact of papers produced by Gülay Hergenç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülay Hergenç. The network helps show where Gülay Hergenç may publish in the future.
Co-authors
The 25 scholars most cited alongside Gülay Hergenç, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 291 | |
| 2 | 2010 | 274 | |
| 3 | 2008 | 236 | |
| 4 | 2006 | 203 | |
| 5 | 2006 | 115 | |
| 6 | 2003 | 109 | |
| 7 | 2007 | 84 | |
| 8 | 2006 | 82 | |
| 9 | 1999 | 73 | |
| 10 | 2005 | 66 | |
| 11 | 2005 | 65 | |
| 12 | 2009 | 60 | |
| 13 | 2008 | 60 | |
| 14 | 2010 | 59 | |
| 15 | 2009 | 58 | |
| 16 | Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. | 2006 | 56 |
| 17 | 2005 | 53 | |
| 18 | 2009 | 50 | |
| 19 | 2007 | 48 | |
| 20 | 2006 | 48 |
About Gülay Hergenç
Gülay Hergenç is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery, Cardiology and Cardiovascular Medicine and Physiology, having authored 79 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (45 papers), Adipokines, Inflammation, and Metabolic Diseases (24 papers), Lipoproteins and Cardiovascular Health (22 papers), Liver Disease Diagnosis and Treatment (14 papers), Cardiovascular Disease and Adiposity (8 papers), Lipid metabolism and disorders (6 papers), Blood properties and coagulation (6 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Endocrine and Autonomic Systems (303 citations), Nephrology (230 citations), Cardiology and Cardiovascular Medicine (647 citations) and Physiology (659 citations). Gülay Hergenç has collaborated with scholars based in Türkiye, United Kingdom and Germany. Frequent co-authors include Altan Onat, Günay Can, Ahmet Karabulut, Hüseyin Uyarel, Hasan Kaya, İbrahim Sarı, Zekeriya Kaya, Erkan Ayhan, Hüsniye Yüksel and Vedat Sansoy. Their work appears in journals such as Metabolism, Atherosclerosis, International Journal of Cardiology, American Journal of Hypertension and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.